Compound ID | 3400
YPT-01
Synonym(s): Yale Phage Therapy 01 | YPT 01 | YPT01
Class: Bacteriophage and/or bacteriophage-derived product
| Agent Type: | Direct acting; Bacteriophage or bacteriphage-derived product; |
| Spectrum of activity: | Gram-negative |
| Target Pathogen: | Active against Pseudomonas aeruginosa; intended indication for chronic P. aeruginosa lung infection and cystic fibrosis |
| Year first mentioned: | 2020 |
| Highest development stage: | Phase 2 (NCT04684641) |
| Development status: | Active |
| External links: | |
| Citation: | https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6808 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.